CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: Common co-signals induced by CD80 and CD86

被引:22
|
作者
Cefai, D
Cai, YC
Hu, H
Rudd, C
机构
[1] DANA FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
关键词
D O I
10.1093/intimm/8.10.1609
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD80 (B7-1) and CD86 (B7-2) ligation of CD28 provide co-stimulatory signals required for optimal lymphokine production in response to TCR zeta-CD3 ligation, CD28 binds to several intracellular proteins including phosphatidylinositol 3-kinase (PI3-kinase), the tyrosine kinase ITK and the growth factor receptor-bound protein/Son of Sevenless (GRB-2/SOS) complex, Previously, we showed that TCR zeta-CD3 and CD28 co-stimulation required PI3-kinase binding to the pYMNM motif of the cytoplasmic domain of the co-receptor, In this study, we have investigated whether CD28-associated PI3-kinase is required for CD80 and CD86 co-stimulation, as well as in co-signaling that involves different primary signals (i.e. TCR zeta-CD3 versus phorbol ester/ionomycin), In the presence of anti-CD3, ligation of CD28 by both CD80 and CD86 was found to induce PI3-kinase recruitment and IL-2 production, Furthermore, mutations at Y-191 and M-194 within the pYMNM motif blocked the ability of both ligands to induce IL-2, CD80 and CD86 therefore share a common signaling pathway leading to IL-2 production. By contrast, CD28 mediated co-stimulation involving receptor ligation plus phorbol ester/ionomycin induced IL-2 independent of PI3-kinase binding to CD28, These data indicate that TCR zeta-CD3-dependent CD80 and CD86 co-signaling requires PI3-kinase binding to the CD28pYMNM motif, while phorbol ester and ionomycin can bypass this requirement in CD28 co-stimulation.
引用
收藏
页码:1609 / 1616
页数:8
相关论文
共 50 条
  • [21] Induction of Death Receptor CD95 and Co-stimulatory Molecules CD80 and CD86 by Meningococcal Capsular Polysaccharide-Loaded Vaccine Nanoparticles
    Ubale, Ruhi V.
    Gala, Rikhav P.
    Zughaier, Susu M.
    D'Souza, Martin J.
    AAPS JOURNAL, 2014, 16 (05): : 986 - 993
  • [22] Induction of Death Receptor CD95 and Co-stimulatory Molecules CD80 and CD86 by Meningococcal Capsular Polysaccharide-Loaded Vaccine Nanoparticles
    Ruhi V. Ubale
    Rikhav P. Gala
    Susu M. Zughaier
    Martin J. D’Souza
    The AAPS Journal, 2014, 16 : 986 - 993
  • [23] CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice
    Mathur, M
    Herrmann, K
    Qin, YM
    Gulmen, F
    Li, XT
    Krimins, R
    Weinstock, J
    Elliott, D
    Bluestone, JA
    Padrid, P
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 21 (04) : 498 - 509
  • [24] CD80/CD28 co-stimulation in human brucellosis
    Skendros, P.
    Boura, P.
    Kamaria, F.
    Raptopoulou-Gigi, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (03): : 400 - 408
  • [25] Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma
    Jia, Jianjun
    Wang, Zineng
    Li, Xiaomao
    Wang, Zhixin
    Wang, Xiaoyu
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 160 (02) : 223 - 227
  • [26] CD28、CD80、CD86在银屑病皮损中的表达
    刘志香
    陈爱军
    黄长征
    涂亚庭
    刘厚君
    王椿森
    华中科技大学学报(医学版), 2003, (06) : 657 - 659
  • [27] Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis
    Cao, Ju
    Zou, Lin
    Luo, Peixin
    Chen, Pu
    Zhang, Liping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2012, 14 (04) : 585 - 592
  • [28] Co-Stimulatory and Inhibitory of T Cell: CD28 Family
    Karaselek, Mehmet Ali
    Reisli, Ismail
    ASTIM ALLERJI IMMUNOLOJI, 2016, 14 (02): : 49 - 55
  • [29] Interferon-β up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes:: significance for treatment of multiple sclerosis
    Marckmann, S
    Wiesemann, E
    Hilse, R
    Trebst, C
    Stangel, M
    Windhagen, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (03): : 499 - 506
  • [30] Development of Novel Monoclonal Antibodies for the Robust Detection of CD28, CD80 and CD86 by Immunohistochemistry in Human Tumors
    Means, Gary
    Sanderson, Russell
    Johnson, Brian
    Larmore, Megan
    Maurer, Mark
    Peng, Stanford
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1704 - 1705